Bluejay Diagnostics (NASDAQ:BJDX) Announces Earnings Results

Bluejay Diagnostics (NASDAQ:BJDX) issued its quarterly earnings data on Monday. The company reported ($112.37) earnings per share for the quarter, Zacks reports.

Bluejay Diagnostics Price Performance

NASDAQ:BJDX opened at $3.73 on Tuesday. Bluejay Diagnostics has a one year low of $3.03 and a one year high of $323.68. The business has a fifty day moving average price of $3.84 and a 200-day moving average price of $4.49. The firm has a market capitalization of $2.06 million, a price-to-earnings ratio of 0.00 and a beta of 0.38.

Bluejay Diagnostics Company Profile

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.